Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,514
datasets available to search
ShareScore release 0.9.0
Dataset results
3,514 results for “cell therapy”
Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT06946485. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
ClinicalTrials.gov study NCT07100080. IPD Sharing: YES. Countries: 25. Publications: 0.
Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00040794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial
ClinicalTrials.gov study NCT01138722. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Validation of a Process for the Manufacture of Stem Cells Isolated From the Nasal Cavity for Innovative Cell Therapy of Traumatized Peripheral Nerves
ClinicalTrials.gov study NCT04020367. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
ClinicalTrials.gov study NCT06213311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)
ClinicalTrials.gov study NCT06196255. IPD Sharing: NO. Countries: 1. Publications: 0.
Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT06752408. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy
ClinicalTrials.gov study NCT05990920. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica
ClinicalTrials.gov study NCT01364246. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00003870. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00601094. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC
ClinicalTrials.gov study NCT03360630. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]
ClinicalTrials.gov study NCT03428607. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
ClinicalTrials.gov study NCT03226704. IPD Sharing: YES. Countries: 1. Publications: 0.
Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
ClinicalTrials.gov study NCT06006650. IPD Sharing: NO. Countries: 1. Publications: 0.
Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial
ClinicalTrials.gov study NCT07039318. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
ClinicalTrials.gov study NCT04061746. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
ClinicalTrials.gov study NCT05464719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
ClinicalTrials.gov study NCT04802733. IPD Sharing: NO. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.